Woodline Partners LP Blueprint Medicines Corp Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

A detailed history of Woodline Partners LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Woodline Partners LP holds 453,578 shares of BPMC stock, worth $41 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

453,578

Previous 880,147 48.47%

Holding current value

$41 Million

Previous $94.9 Million 55.79%

% of portfolio

0.38%

Previous 0.95%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$84.1 - $120.5 $35.9 Million - $51.4 Million	-426,569 Reduced 48.47%	453,578 $41.9 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $4.51 Million - $5.76 Million	52,974 Added 6.4%	880,147 $94.9 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $929,259 - $1.27 Million	12,700 Added 1.56%	827,173 $78.5 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $9.34 Million - $19.7 Million	212,446 Added 35.29%	814,473 $75.1 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $14.6 Million - $20.5 Million	310,665 Added 106.63%	602,027 $30.2 Million
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $7.85 Million - $12.3 Million	185,985 Added 176.49%	291,362 $18.4 Million
Q1 2023 May 15, 2023	SELL	$37.97 - $50.0 $5.14 Million - $6.77 Million	-135,317 Reduced 56.22%	105,377 $4.74 Million
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $6.05 Million - $9.79 Million	147,307 Added 157.74%	240,694 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $1.13 Million - $1.76 Million	-22,700 Reduced 19.55%	93,387 $6.15 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $4.13 Million - $6.4 Million	91,214 Added 366.72%	116,087 $5.86 Million
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $2.01 Million - $4.09 Million	-37,182 Reduced 59.92%	24,873 $1.59 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $10.4 Million - $12.8 Million	-109,980 Reduced 63.93%	62,055 $6.65 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $9.31 Million - $12.6 Million	114,979 Added 201.52%	172,035 $17.7 Million
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $2.64 Million - $3.22 Million	-31,850 Reduced 35.82%	57,056 $5.02 Million
Q1 2021 May 17, 2021	BUY	$90.71 - $108.28 $8.06 Million - $9.63 Million	88,906 New	88,906 $8.64 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Blueprint Medicines Corp Transaction History